Center-Authored Papers

Filters: Author is Fero, Matthew L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Flowers MED, Storer BE, Carpenter PA, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem H-P, Fero ML, Georges GE et al..  2008.  Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(12):1380-4. Abstract
Chien WM, Garrison K, Orthel J, Rabin S, Fero ML.  2005.  Tissue specific knockout and knockon mutations of p27Kip1. Cold Spring Harbor 70th Symposium .
Jatzek A, Marie Tejera M, Plisch EH, Fero ML, Suresh M.  2012.  T-cell intrinsic and extrinsic mechanisms of p27(Kip1) in the regulation of CD8 T-cell memory.. Immunology and cell biology. Abstract
S
Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM et al..  1996.  A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.. Cell. 85(5):733-44. Abstract
Morgan WF, Bodycote J, Doida Y, Fero ML, Hahn P, Kapp LN.  1986.  Spontaneous and 3-aminobenzamide-induced sister-chromatid exchange frequencies estimated by ring chromosome analysis.. Mutagenesis. 1(6):453-9. Abstract
R
Fero ML, Lowenheim H, Gu R, Sudra A, Kil J.  1999.  Regeneration of Auditory Sensory Cells Via p27Kip1 Antagonism. Cold Spring Harbor Cell Cycle Symposium .
P
Vázquez-Chona FR, Swan A, Ferrell DW, Jiang L, Baehr W, Chien W-M, Fero ML, Marc RE, Levine EM.  2011.  Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function.. BMC neuroscience. 12:98. Abstract
Hatton BA, Ellison DW, Gajjar A, Kool M, Fero M, Olson JM.  2013.  Prognostic value and functional consequences of cell cycle inhibitor p27Kip1 loss in medulloblastoma.. Biomarker research. 1(1):14. Abstract
Gronseth CM, McElhone SE, Storer BE, Kroeger KA, Sandhu V, Fero ML, Appelbaum FR, Estey EH, Fang M.  2015.  Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.. Cancer. Abstract
Morgan WF, Doida Y, Fero ML, Guo XC, Shadley JD.  1986.  Potentiation of sister chromatid exchange by 3-aminobenzamide is not modulated by topoisomerases or proteases.. Environmental mutagenesis. 8(4):487-93. Abstract
Fero ML, Randel E, Gurley K, Roberts J, Kemp C.  1998.  p27kip1: A Haploinsufficient Tumor Suppressor. Gordon Conference on DNA alterations in transformed cells .
Durand B, Fero ML, Roberts JM, Raff MC.  1998.  p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation.. Current biology : CB. 8(8):431-40. Abstract
Levine EM, Close J, Fero M, Ostrovsky A, Reh TA.  2000.  p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina.. Developmental biology. 219(2):299-314. Abstract
Oesterle EC, Chien W-M, Campbell S, Nellimarla P, Fero ML.  2011.  p27(Kip1) is required to maintain proliferative quiescence in the adult cochlea and pituitary.. Cell cycle (Georgetown, Tex.). 10(8):1237-48. Abstract
Godin JD, Thomas N, Laguesse S, Malinouskaya L, Close P, Malaise O, Purnelle A, Raineteau O, Campbell K, Fero M et al..  2012.  p27(Kip1) Is a Microtubule-Associated Protein that Promotes Microtubule Polymerization during Neuron Migration.. Developmental cell. 23(4):729-44. Abstract
Fero ML, Kemp CJ.  2002.  p27 (Kip1) . The Encylopedia of Molecular Medicine. :2363-2366.
Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ.  1999.  The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.. The EMBO journal. 18(6):1571-83. Abstract
N
Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM.  1999.  A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.. Current biology : CB. 9(4):163-73. Abstract
Walkley CR, Fero ML, Chien W-M, Purton LE, McArthur GA.  2005.  Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells.. Nature cell biology. 7(2):172-8. Abstract
M
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ.  1998.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression.. Nature. 396(6707):177-80. Abstract
Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ.  1999.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1).. The Journal of clinical investigation. 103(5):597-604. Abstract
Kuppers DA, Schmitt TM, Hwang HC, Samraj L, Clurman BE, Fero ML.  2017.  The miR-106a~363Xpcl1 miRNA cluster induces murine T cell lymphoma despite transcriptional activation of the p27Kip1 cell cycle inhibitor.. Oncotarget. Abstract
Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, Clurman BE, Roberts JM.  2007.  A mechanism misregulating p27 in tumors discovered in a functional genomic screen.. PLoS genetics. 3(12):e219. Abstract
McArthur GA, Foley KP, Fero ML, Walkley CR, Deans AJ, Roberts JM, Eisenman RN.  2002.  MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity.. Molecular and cellular biology. 22(9):3014-23. Abstract
I
Kuppers D, Schmitt T, Clurman B, Hwang H, Fero ML.  2012.  Interaction of miR-106a~363Xpcl1 and p27Kip1 in thymopoiesis and lymphomagenesis. AACR Symposium on non-coding RNAs.